PTGX

Protagonist Therapeutics, Inc#69 · 2024EPB

Yearly return

+65%

Peak return

+109%

Max drawdown

-32%

ADR (20 days)

+4.2%

Base

18 days / -23.7%

Prior run

+105%

Breakout volume

6.1x

Pivot

$28.10

Catalyst Auftrag/Partnerschaft2024-02-02Protagonist (PTGX) Up 14% on Licensing Deal With TakedaZacks Investment Research

Auftrag, Partnerschaft oder kommerzieller Beweis als Umsatzhebel.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare PTGX with the current market directly.